Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not have to have your GP's permission to start Mounjaro through a private pharmacy. That is the honest answer. Private prescribers can assess you independently, and many people begin treatment this way every week. What matters is whether the prescriber assessing you has the full clinical picture — and that is where the 'without informing your GP' question gets more nuanced. Mounjaro (tirzepatide) is a prescription-only medicine, so a real clinical assessment by a qualified prescriber is a legal requirement regardless of route.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who search this phrase are worried about something specific: they don't want their GP to block their access, or they feel uncomfortable raising weight with a doctor they've seen for years. That's completely understandable. The good news is that 'GP notification' and 'GP permission' are not the same thing.
Private prescribers assess you on their own clinical authority. They do not need a note from your surgery before they can prescribe. What GPhC guidance does ask is that prescribers consider notifying your GP once treatment begins, so your wider health record stays accurate. This is a safety measure, it means a GP treating you for something unrelated knows what medicines you're taking. It protects you; it doesn't gatekeep you.
If you'd prefer a prescriber handles notification on your behalf rather than you raising it yourself, that's a conversation worth having directly. Our page on Mounjaro and GP notification sets out exactly what the guidance says and why it exists.
What the reviews reveal is something slightly different: patients who had thorough consultations (where medicines, medical history and lifestyle were genuinely discussed) report better experiences and fewer surprises than those who felt the process was rushed.
Mounjaro reviews in the UK tend to cluster around a handful of themes: the dose-escalation experience, gastrointestinal side effects in the first few weeks, and whether the support on offer matched what was promised at sign-up. The GP-notification question rarely appears as a standalone complaint. When it does come up, it's almost always framed as a pleasant surprise, patients expected friction, and found none.
The broader picture from Mounjaro reviews shows that nausea, fatigue and reduced appetite are the most commonly reported early effects. These tend to ease as the body adjusts, typically within the first two to four weeks. What makes the difference, according to patient accounts, is whether someone was told to expect them in advance and given a clear point of contact when questions arose.
Reviews of the 5mg dose specifically (the first titration step) follow a similar pattern. You can read a more granular account of that experience on our 5mg Mounjaro reviews page. The short version: most people find the transition manageable when they know what's coming.
NHS guidance on tirzepatide, published on the NHS medicines pages, describes the known side-effect profile clearly and is worth reading alongside any review you come across online.
A good consultation for Mounjaro covers more than BMI. Prescribers look at current medicines (certain diabetes medications interact with tirzepatide), medical history (pancreatitis, thyroid conditions and a small number of other factors affect suitability), and whether someone understands what the first few weeks involve. None of that requires your GP to be in the loop beforehand, but it does require you to be honest with the prescriber.
The MHRA issued guidance in January 2026 specifically highlighting acute pancreatitis as a known, though uncommon, serious side effect of GLP-1 medicines. Severe stomach pain that spreads to the back, especially with vomiting, needs urgent medical attention. That information needs to reach every patient starting treatment, and a proper consultation is how that happens.
For anyone considering private treatment, our tirzepatide overview covers the full licensed indication, and the Mounjaro treatment page explains how our process works in practice. The clinical team is led by our Independent Prescriber, who personally reviews each consultation.
When patients report negative experiences (missed side-effect warnings, a dose increase that felt too fast, no one available to call when something didn't feel right) the common thread is rarely GP involvement. It's the depth of the assessment and the aftercare on offer.
The question 'can I get Mounjaro without informing my GP' is answerable quickly: yes, through a private pharmacy, following a clinical assessment. The more useful question is whether the pharmacy you're considering has identity verification, live weight checks, a real prescriber reading your answers, and a line to call seven days a week if you need it. That's the standard worth holding providers to.
A sense of what to look for (and what red flags to avoid) is covered in our weight loss treatment overview. If you want to understand how prices vary and what's typically included, the Mounjaro cost page sets that out clearly.
If you have questions before committing to anything, our FAQs cover the most common ones. When you're ready to take the next step, you're welcome to speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.